Eli M. Roth
Eli M. Roth publishes mostly in Surgery, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine, on topics such as Lipoproteins and Cardiovascular Health, Diabetes, Cardiovascular Risks, and Lipoproteins and Antiplatelet Therapy and Cardiovascular Diseases.
- World rank
- #700,705 of 7,710,434 ranked researchers
- Rank in United States
- #236,895 of 1,627,098
- Works
- 92
- Citations
- 3.7k
- Citations per work
- 40.5
What does Eli M. Roth research?
Eli M. Roth's work is mostly in Medicine (56%), Biochemistry, Genetics and Molecular Biology (10%), Economics, Econometrics and Finance (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences5256.2%
- Medicine5256.2%
- Everything else2527.3%
- Life Sciences99.9%
- Social Sciences66.6%
- 1Surgery32% of their works
- 2Endocrinology, Diabetes and Metabolism12% of their works
- 3Cardiology and Cardiovascular Medicine12% of their works
- 4Economics and Econometrics7% of their works
- 5Cancer Research6% of their works
- 6Molecular Biology4% of their works
Research topics
- Lipoproteins and Cardiovascular Health
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Antiplatelet Therapy and Cardiovascular Diseases
- Cancer, Lipids, and Metabolism
- Health Systems, Economic Evaluations, Quality of Life
- Pharmaceutical Economics and Policy
- Diabetes Treatment and Management
- Acute Myocardial Infarction Research
Which keywords describe Eli M. Roth's research?
The keywords of their largest research topics: Statins, Cardiovascular Disease Prevention, Cholesterol-lowering, Cholesterol, Cardiovascular Disease, Diabetes, Metabolic Syndrome and Aspirin.
- Acute Coronary Syndromes
- Cardiovascular Outcomes
- Generic Drugs
- Cost-effectiveness Analysis
- Fatty Acid Synthase
- Aspirin
- Diabetes
- Cholesterol
- Cardiovascular Disease Prevention
- Statins
- Cholesterol-lowering
- Cardiovascular Disease
- Metabolic Syndrome
- Clopidogrel
- Lipid Metabolism
- Drug Development Costs
- Quality of Life
- Type 2 Diabetes
- Myocardial Infarction
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 19 words, with their numbers
- Statins732 topics
- Cardiovascular Disease Prevention621 topic
- Cholesterol-lowering621 topic
- Cholesterol272 topics
- Cardiovascular Disease222 topics
- Diabetes161 topic
- Metabolic Syndrome161 topic
- Aspirin131 topic
- Clopidogrel131 topic
- Fatty Acid Synthase111 topic
- Lipid Metabolism111 topic
- Cost-effectiveness Analysis81 topic
- Drug Development Costs81 topic
- Generic Drugs81 topic
- Quality of Life81 topic
- Cardiovascular Outcomes71 topic
- Type 2 Diabetes71 topic
- Acute Coronary Syndromes61 topic
- Myocardial Infarction61 topic
Where does Eli M. Roth work?
Eli M. Roth's main affiliation in the publication record is Sterling Research Group, United States.
How many publications and citations does Eli M. Roth have?
OpenAlex counts 92 works and 3,727 citations for Eli M. Roth, an h-index of 27, ranking #700,705 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Eli M. Roth. Posts are plain text and can be reported.